- Home
- LEGN
as 03-28-2025 4:00pm EST
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 7.0B | IPO Year: | 2020 |
| Target Price: | $79.17 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.97 | EPS Growth: | N/A |
| 52 Week Low/High: | $30.17 - $60.87 | Next Earning Date: | 03-11-2025 |
| Revenue: | $627,241,000 | Revenue Growth: | 119.97% |
| Revenue Growth (this year): | 66.6% | Revenue Growth (next year): | 49.28% |
Latest Legend Biotech Corporation News
LEGN Breaking Stock News: Dive into LEGN Ticker-Specific Updates for Smart Investing
Simply Wall St.
17 days ago
Legend Biotech Full Year 2024 Earnings: Beats Expectations
GuruFocus.com
17 days ago
Legend Biotech Corp (LEGN) Q4 2024 Earnings Call Highlights: Record CARVYKTI Sales and ...
Thomson Reuters StreetEvents
17 days ago
Q4 2024 Legend Biotech Corp Earnings Call
Zacks
18 days ago
Compared to Estimates, Legend Biotech (LEGN) Q4 Earnings: A Look at Key Metrics
MT Newswires
18 days ago
Legend Biotech's Q4 Net Loss Narrows, Revenue Rises
GlobeNewswire
18 days ago
Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights
GlobeNewswire
a month ago
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results
Insider Monkey
a month ago
Why Legend Biotech Corporation (LEGN) is the Most Oversold Pharma Stock to Buy According to Analysts
Compare LEGN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LEGN Legend Biotech Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.